Electroacupuncture regulates FTO/Nrf2/NLRP3 axis-mediated pyroptosis in cerebral ischemia–reperfusion injury
Neuroreport,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 18, 2025
Electroacupuncture
(EA)
demonstrates
neuroprotective
in
cerebral
ischemia–reperfusion
(I/R)
injury.
N6-methyladenosine
(m6A)
is
found
to
contribute
the
pathogenesis
of
neurological
conditions
recently.
The
objective
this
study
investigate
effects
EA
on
m6A
and
related
mechanism
I/R
After
middle
artery
occlusion/reperfusion
(MCAO/R)
operation
was
used
establish
rat
models
with
injury,
applied
Baihui
(GV20)
Dazhui
(GV14)
once
daily
for
7
consecutive
days.
Subsequently,
modified
Neurological
Severity
Score,
2,3,5-triphenyltetrazolium
chloride
staining,
hematoxylin
eosin
staining
were
performed
assess
damage.
To
potential
target,
total
RNA
level
relevant
regulators
(METTL3,
METTL14,
WTAP,
FTO,
ALKBH5)
examined.
In
next
step,
Nrf2,
NLRP3,
IL-18,
IL-1β,
TUNEL-positive
rates
detected,
while
shRNA-FTO
administered
suppress
FTO
expression.
improved
neurobehavioral
disorders,
infarct
volume,
pathological
damage
induced
by
Mechanically,
reduced
selectively
regulating
but
not
METTL3,
ALKBH5.
Furthermore,
could
enhance
Nrf2
rates,
which
reversed
injection.
Our
findings
indicate
that
may
alleviate
FTO/Nrf2/NLRP3
axis-mediated
pyroptosis
providing
a
more
unified
understanding
EA.
Specifically,
intervention
appears
promote
expression
leading
reduction
level,
activates
subsequently
suppresses
NLRP3-mediated
pyroptosis.
Language: Английский
A comprehensive review of m6 A methylation in coronary heart disease
Journal of Molecular Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 10, 2025
Language: Английский
From bone marrow mesenchymal stem cells to diseases: the crucial role of m6A methylation in orthopedics
Jing Li,
No information about this author
Chu Zhang,
No information about this author
Wen Yin
No information about this author
et al.
Stem Cell Research & Therapy,
Journal Year:
2025,
Volume and Issue:
16(1)
Published: May 6, 2025
Elucidating
the
molecular
mechanisms
underlying
orthopedic
diseases
is
crucial
for
guiding
therapeutic
strategies
and
developing
innovative
interventions.
N6-methyladenosine
(m6A)-an
epitranscriptomic
modification-has
emerged
as
a
key
regulator
of
cellular
fate
tissue
homeostasis.
Specifically,
m6A
plays
pivotal
role
in
several
RNA
biological
processes
such
precursor
splicing,
3'-end
processing,
nuclear
export,
translation,
stability.
Recent
advancements
indicate
that
methylation
regulates
stem
cell
proliferation
osteogenic
differentiation
by
modulating
various
signaling
pathways.
Extensive
research
has
shown
abnormalities
contribute
significantly
to
onset
progression
osteoporosis
(OP),
osteoarthritis
(OA),
rheumatoid
arthritis
(RA),
bone
tumors.
This
review
aims
summarize
proteases
involved
their
functions.
The
detailed
which
marrow
mesenchymal
cells
(BMSCs)
through
direct
indirect
ways
are
also
discussed,
with
focus
on
specific
Finally,
this
analyzes
roles
modification
development
multiple
diseases,
offering
comprehensive
understanding
pathophysiology
these
conditions
proposing
new
directions
targets
treatment
strategies.
Language: Английский